Zydus Lifesciences Slapped Rs 3.28 Cr GST Demand
Mumbai: Zydus Lifesciences Limited has received a tax demand order amounting to Rs 3.28 crore from the Assistant Commissioner of State Tax, Gujarat, related to the financial year 2019-20. The…
Mumbai: Zydus Lifesciences Limited has received a tax demand order amounting to Rs 3.28 crore from the Assistant Commissioner of State Tax, Gujarat, related to the financial year 2019-20. The…
Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has entered into a marketing and distribution agreement with Germany-based pharmaceutical company STADA Arzneimittel AG…
Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced key changes to its board following shareholder approval via postal ballot, reinforcing its leadership structure and governance framework. The company has appointed…
New Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March 2026, the Drugs Control Administration (DCA), Telangana,…
Johannesburg: Novo Nordisk is cutting South African prices of its weight-loss drug Wegovy for a second time since it launched in August, local executives said on Wednesday, pointing to fierce…
New Delhi: In a significant development in an ongoing pharmaceutical dispute, the Supreme Court of India has declined to interfere with an order of the Allahabad High Court in a…
New Delhi: Reflecting ongoing concerns over drug quality in India, the Central Drugs Standard Control Organisation (CDSCO) has flagged 134 drug samples as Not of Standard Quality (NSQ) in its…
Mumbai: The US-based private equity firm Warburg Pincus is in advanced discussions to acquire the formulations business of Maneesh Pharmaceuticals in a deal estimated to be valued at around Rs…
Mexico City: Pharmaceutical company Merck is nearing a roughly USD 6 billion all-cash deal to acquire biotech firm Terns Pharma, the Financial Times reported on Tuesday, citing people familiar with…
Bengaluru: The U.S. drugmaker Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed more than 70% efficacy in a late-stage trial. Pfizer said it had planned…